Skip to content

NEI Research News

Thanks to the work of NEI scientists and grantees, we’re constantly learning new information about the causes and treatment of vision disorders. Get the latest updates about their work — along with other news about NEI.

Source
244 items
blank

AI-based systems can help identify rapidly advancing age-related macular degeneration

March 14, 2023

Researchers supported by the NEI are developing artificial intelligence/machine learning (AI/ML)-based systems that not only screen for AMD but also predict which patients will likely progress to late within two years.
Older woman's right eye

New insights: Eye damage in Alzheimer’s disease patients

March 3, 2023

Cedars-Sinai investigators map changes to the retina that correspond to brain changes in the early stage of Alzheimer's disease, opening a path to earlier diagnosis.
Woman using eyedrops

Eye experts weigh in on artificial tears in midst of infectious outbreak

March 2, 2023

Questions remain about artificial tears linked to an outbreak of Pseudomonas aeruginosa infections involving 68 people in 16 states, including 5 cases of vision loss, as well as lung and urinary tract infections, and one death.
Patient wearing brain pressure measuring device over their eyes.

Low brain pressure could be a risk factor for developing glaucoma

February 13, 2023

A recent international clinical study demonstrates that low intracranial pressure correlates with impaired patient vision, especially in the nasal zone.

Early anti-VEGF treatment of diabetic retinopathy yields no benefit to visual acuity

February 7, 2023

While early treatment of diabetes-related eye disease slowed progression to severe disease, it did not improve visual acuity compared with treating more severe disease once it developed, according to a clinical study from the DRCR Retina Network.
Building photo

UC Davis Health opens new state-of-the-art eye care facility

December 9, 2022

The University of California Davis welcomed patients to its new, state-of-the-art Ernest E. Tschannen Eye Institute Building.
retina blood vessels

One of two widely used AMD drugs outperforms other at weaning patients off treatment at one year, preliminary study shows

November 30, 2022

A pilot study of 106 patients with “wet” AMD revealed that nearly half of patients treated with Eylea could safely stop therapy after one year, compared to only 17% of patients treated with Avastin.
Decorative

Putting stem cell-based therapies in context

November 16, 2022

Rogue clinics offer stem cell-based therapies that haven’t been tested for safety and efficacy. When communicating to the public about stem cell-based therapies, it is important to put any treatment claims in context.
Top-down sectional views of 4 brain scans, showing missing hemispheres.

Word and face recognition can be adequately supported with half a brain, study finds

October 26, 2022

An unprecedented study of brain plasticity and visual perception found that people who, as children, had undergone surgery removing half of their brain correctly recognized differences between pairs of words or faces more than 80% of the time.
Earth

Iriqat and Lee deliver Global Health Vision Lectures

October 7, 2022

Series fosters global collaboration and exchange of information among international vision researchers and eye health clinical scientists

Want more news from NEI?

Subscribe to our news feed to stay up to date on vision and eye health research!

Success! Link copied to clipboard.

Copy to clipboard failed.

You can also browse older stories in our news archive

NEI Press Office

We can connect media professionals with the latest vision research info. Get in touch!


Phone: 301-496-5248